Cargando…
Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing
BACKGROUND: Trimethylaminuria (TMAU) is a genetic disorder whereby people cannot convert trimethylamine (TMA) to its oxidized form (TMAO), a process that requires the liver enzyme FMO3. Loss-of-function variants in the FMO3 gene are a known cause of TMAU. In addition to the inability to metabolize T...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310055/ https://www.ncbi.nlm.nih.gov/pubmed/28196478 http://dx.doi.org/10.1186/s12881-017-0369-8 |
_version_ | 1782507810536292352 |
---|---|
author | Guo, Yiran Hwang, Liang-Dar Li, Jiankang Eades, Jason Yu, Chung Wen Mansfield, Corrine Burdick-Will, Alexis Chang, Xiao Chen, Yulan Duke, Fujiko F. Zhang, Jianguo Fakharzadeh, Steven Fennessey, Paul Keating, Brendan J. Jiang, Hui Hakonarson, Hakon Reed, Danielle R. Preti, George |
author_facet | Guo, Yiran Hwang, Liang-Dar Li, Jiankang Eades, Jason Yu, Chung Wen Mansfield, Corrine Burdick-Will, Alexis Chang, Xiao Chen, Yulan Duke, Fujiko F. Zhang, Jianguo Fakharzadeh, Steven Fennessey, Paul Keating, Brendan J. Jiang, Hui Hakonarson, Hakon Reed, Danielle R. Preti, George |
author_sort | Guo, Yiran |
collection | PubMed |
description | BACKGROUND: Trimethylaminuria (TMAU) is a genetic disorder whereby people cannot convert trimethylamine (TMA) to its oxidized form (TMAO), a process that requires the liver enzyme FMO3. Loss-of-function variants in the FMO3 gene are a known cause of TMAU. In addition to the inability to metabolize TMA precursors like choline, patients often emit a characteristic odor because while TMAO is odorless, TMA has a fishy smell. The Monell Chemical Senses Center is a research institute with a program to evaluate people with odor complaints for TMAU. METHODS: Here we evaluated ten subjects by (1) odor evaluation by a trained sensory panel, (2) analysis of their urine concentration of TMA relative to TMAO before and after choline ingestion, and (3) whole exome sequencing as well as subsequent variant analysis of all ten samples to investigate the genetics of TMAU. RESULTS: While all subjects reported they often emitted a fish-like odor, none had this malodor during sensory evaluation. However, all were impaired in their ability to produce >90% TMAO/TMA in their urine and thus met the criteria for TMAU. To probe for genetic causes, the exome of each subject was sequenced, and variants were filtered by genes with a known (FMO3) or expected effect on TMA metabolism function (other oxidoreductases). We filtered the remaining variants by allele frequency and predicated functional effects. We identified one subject that had a rare loss-of-function FMO3 variant and six with more common decreased-function variants. In other oxidoreductases genes, five subjects had four novel rare single-nucleotide polymorphisms as well as one rare insertion/deletion. Novel in this context means no investigators have previously linked these variants to TMAU although they are in dbSNP. CONCLUSIONS: Thus, variants in genes other than FMO3 may cause TMAU and the genetic variants identified here serve as a starting point for future studies of impaired TMA metabolism. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-017-0369-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5310055 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53100552017-03-13 Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing Guo, Yiran Hwang, Liang-Dar Li, Jiankang Eades, Jason Yu, Chung Wen Mansfield, Corrine Burdick-Will, Alexis Chang, Xiao Chen, Yulan Duke, Fujiko F. Zhang, Jianguo Fakharzadeh, Steven Fennessey, Paul Keating, Brendan J. Jiang, Hui Hakonarson, Hakon Reed, Danielle R. Preti, George BMC Med Genet Research Article BACKGROUND: Trimethylaminuria (TMAU) is a genetic disorder whereby people cannot convert trimethylamine (TMA) to its oxidized form (TMAO), a process that requires the liver enzyme FMO3. Loss-of-function variants in the FMO3 gene are a known cause of TMAU. In addition to the inability to metabolize TMA precursors like choline, patients often emit a characteristic odor because while TMAO is odorless, TMA has a fishy smell. The Monell Chemical Senses Center is a research institute with a program to evaluate people with odor complaints for TMAU. METHODS: Here we evaluated ten subjects by (1) odor evaluation by a trained sensory panel, (2) analysis of their urine concentration of TMA relative to TMAO before and after choline ingestion, and (3) whole exome sequencing as well as subsequent variant analysis of all ten samples to investigate the genetics of TMAU. RESULTS: While all subjects reported they often emitted a fish-like odor, none had this malodor during sensory evaluation. However, all were impaired in their ability to produce >90% TMAO/TMA in their urine and thus met the criteria for TMAU. To probe for genetic causes, the exome of each subject was sequenced, and variants were filtered by genes with a known (FMO3) or expected effect on TMA metabolism function (other oxidoreductases). We filtered the remaining variants by allele frequency and predicated functional effects. We identified one subject that had a rare loss-of-function FMO3 variant and six with more common decreased-function variants. In other oxidoreductases genes, five subjects had four novel rare single-nucleotide polymorphisms as well as one rare insertion/deletion. Novel in this context means no investigators have previously linked these variants to TMAU although they are in dbSNP. CONCLUSIONS: Thus, variants in genes other than FMO3 may cause TMAU and the genetic variants identified here serve as a starting point for future studies of impaired TMA metabolism. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-017-0369-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-15 /pmc/articles/PMC5310055/ /pubmed/28196478 http://dx.doi.org/10.1186/s12881-017-0369-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Guo, Yiran Hwang, Liang-Dar Li, Jiankang Eades, Jason Yu, Chung Wen Mansfield, Corrine Burdick-Will, Alexis Chang, Xiao Chen, Yulan Duke, Fujiko F. Zhang, Jianguo Fakharzadeh, Steven Fennessey, Paul Keating, Brendan J. Jiang, Hui Hakonarson, Hakon Reed, Danielle R. Preti, George Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing |
title | Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing |
title_full | Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing |
title_fullStr | Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing |
title_full_unstemmed | Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing |
title_short | Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing |
title_sort | genetic analysis of impaired trimethylamine metabolism using whole exome sequencing |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310055/ https://www.ncbi.nlm.nih.gov/pubmed/28196478 http://dx.doi.org/10.1186/s12881-017-0369-8 |
work_keys_str_mv | AT guoyiran geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT hwangliangdar geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT lijiankang geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT eadesjason geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT yuchungwen geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT mansfieldcorrine geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT burdickwillalexis geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT changxiao geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT chenyulan geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT dukefujikof geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT zhangjianguo geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT fakharzadehsteven geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT fennesseypaul geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT keatingbrendanj geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT jianghui geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT hakonarsonhakon geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT reeddanieller geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing AT pretigeorge geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing |